If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
41.50    -1.00 (-2.33%)
Bid:
40.00
Ask:
43.00
Spread: 3.00 (7.50%)
Market Cap: £18.47m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Directorate Changes

31 Mar 2026 07:00

RNS Number : 7008Y
Manolete Partners PLC
31 March 2026
 

31 March 2026

 

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Directorate Changes

 

Manolete is delighted to announce the appointment of Marcia Shekerdemian KC to the Board as a Non-Executive Director with effect from 31 March 2026.

 

Marcia is a leading barrister in all aspects of contentious and non-contentious insolvency, company and partnership law as well as commercial litigation. She sat in the High Court as a Deputy Insolvency and Companies Court Judge from 2000 to 2025, and remains in private practice as a barrister as a member of Wilberforce Chambers. Marcia will join the Audit Committee and chair the Remuneration Committee.

 

She will replace Dr. Stephen Baister on the Board, who will step down as a Non-Executive Director with effect from the same date. Stephen will continue to provide consultancy to the Company.

 

Lord Leigh of Hurley, Chairman of Manolete said:

 

"I am delighted that Marcia has agreed to join the Board. She brings extensive knowledge across insolvency litigation and I look forward to working with her over the coming years.

 

"I would also like to thank Stephen for his work as a senior adviser to Manolete and then as a Non-Executive Director since 2018. His knowledge of insolvency law and critical thinking have been very important to the Board. I am pleased that he will continue to deliver the benefits of his deep expertise as a consultant to the Company."

 

Marcia Shekerdemian KC, commenting on her appointment as a Non-Executive Director of Manolete said:

 

"As the UK's leading insolvency claims financing company, Manolete is deservedly well-known and respected for the quality and efficacy of its work helping creditors increase returns on claims that otherwise wouldn't be pursued. The Company has a proven, unique business model and I am looking forward to supporting the Board to build on Manolete's growth to date."

 

 

The following information is disclosed pursuant to paragraph (g) of Schedule 2 to the AIM Rules:

 

Marcia Shekerdemian KC aged 62 is currently a director of Middle Temple Charity, and in the last 5 years has been a director of the Leonard Cheshire Disability Charity. There are no further items to be disclosed.

 

For further information please contact:

 

Manolete Partners

Mena Halton (Chief Executive Officer) via Houston

Will Sawyer (Chief Financial Officer)

 

Canaccord (NOMAD and Sole Broker) +44 (0)20 7523 8000

Stuart Andrews

Emma Gabriel

Harry Rees

 

Houston (Financial PR) +44 (0)77 3303 2695

Charlie Barker +44 (0)20 4529 0549

Nick Jackman

Manolete@houston.co.uk

 

About Manolete Partners PLC

Manolete Partners Plc is the UK's leading insolvency claims financing company. Serving a growing market worth over £500 million annually, the Company has a highly experienced team with coverage across the UK and a proven track record of generating strong historic returns across over 1,300 cases financed and completed to date.

 

Widely recognised as the industry leader, Manolete is the only company in the insolvency litigation funding section to be ranked in Band 1 of the legal industry's prestigious Chambers Guide five times. The Company is also five-time winner of 'Insolvency Litigation Funder of the Year' at the Turnaround, Restructuring and Insolvency Industry Awards.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLGDXGXXDGLG
Date   Source Headline
30th Nov 202111:03 amRNSDirector/PDMR Dealings
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results
3rd Nov 20217:00 amRNSNotice of Half Year Results
6th Oct 20217:00 amRNSTrading Update
1st Oct 20212:52 pmRNSDirector/PDMR Dealings
22nd Sep 20219:57 amRNSResult of AGM
21st Sep 20217:00 amRNSAGM Statement
9th Jul 20214:30 pmRNSPosting of Annual Report and Notice of AGM
25th Jun 20217:00 amRNSManolete Partners ranked in Band 1 by Chambers
24th Jun 202112:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:00 amRNSFull Year Results
23rd Jun 20217:00 amRNSAppointment of Chairman Designate
14th Jun 202110:29 amRNSNotice of Full Year Results
1st Mar 202112:45 pmRNSTR-1: Notification of Major Holdings
23rd Feb 20217:00 amRNSUpdated Investor Presentation
22nd Feb 20217:00 amRNSInvestor Presentation
10th Feb 202111:28 amRNSTR-1: Notification of Major Holdings
10th Feb 20217:00 amRNSDirector/PDMR Dealings
9th Feb 20217:00 amRNSDirector/PDMR Dealings
1st Feb 20217:21 amRNSDirector/PDMR Dealings
29th Jan 20217:00 amRNSDirector/PDMR Dealings
28th Jan 20211:09 pmRNSTR-1: Notification of Major Holdings
28th Jan 202111:24 amRNSTR-1: Notification of Major Holdings
27th Jan 20212:42 pmRNSTR-1: Notification of Major Holdings
26th Jan 20214:40 pmRNSSecond Price Monitoring Extn
26th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20212:47 pmRNSQ3 Trading Update
5th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Dec 20202:02 pmRNSTR-1: Notification of Major Holdings
18th Nov 202010:29 amRNSLarge Case Update
12th Nov 20207:00 amRNSFurther Significant Case Completion
10th Nov 20207:00 amRNSHalf Year Results
3rd Nov 20202:52 pmRNSNotice of Half Year Results
1st Oct 20207:00 amRNSGrant of Share Options
22nd Sep 202011:51 amRNSResult of AGM
17th Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20204:23 pmRNSTrading Update - Significant Case Completion
24th Jul 20205:20 pmRNSNotification of Major Holdings
15th Jul 20204:02 pmRNSNotification of Major Holdings
14th Jul 20207:00 amRNSResponse to Article Published by ShareProphets
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:46 pmRNSPosting of Annual Report and Notice of AGM
13th Jul 20209:05 amRNSSecond Price Monitoring Extn
13th Jul 20209:00 amRNSPrice Monitoring Extension
3rd Jul 20207:05 amRNSAppointment of Joint Broker
3rd Jul 20207:00 amRNSFull Year Results
30th Jun 20203:56 pmRNSNotice of Full Year Results
29th Jun 202011:08 amRNSUpdate on Judgment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.